Anticancer properties of novel 4-methylene-1,2-diphenylpyrazolidin-3-ones

Chem Biol Drug Des. 2015 Nov;86(5):961-8. doi: 10.1111/cbdd.12565. Epub 2015 Apr 21.

Abstract

The limited success of the currently used antitumor therapies is the driving force for organic chemists to seek new lead structures with anticancer potential. Two α-methylene-γ-lactams with an additional nitrogen atom in the lactam ring, 5-vinyl-1,2-diphenyl-4-methylenepyrazolidin-3-one (2a) and 5-phenyl-1,2-diphenyl-4-methylenepyrazolidin-3-one (2b) have been synthesized. Their anticancer activity was assessed in MCF-7 cells. Both compounds inhibited cell proliferation and induced DNA damage and apoptosis, with 2a being the more potent analog. Synergistic effects of 2a used in combination with known anticancer drugs, 5-fluorouracil, taxol, and oxaliplatin were evaluated. Compound 2a significantly enhanced the antitumor action of oxaliplatin and 5-fluorouracil, but not taxol.

Keywords: DNA damage; anticancer drugs; apoptosis; breast cancer; cell proliferation; α-Methylene-γ-lactams.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Breast / drug effects
  • Breast / metabolism
  • Breast / pathology
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology
  • Cell Proliferation / drug effects
  • DNA Damage / drug effects*
  • Female
  • Humans
  • MCF-7 Cells
  • Pyrazolones / chemistry
  • Pyrazolones / pharmacology*

Substances

  • 5-vinyl-1,2-diphenyl-4-methylenepyrazolidin-3-one
  • Antineoplastic Agents
  • Pyrazolones